PHILIP REASBECK: Open Payments
NPI 1376896811 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,339 in 265 payments from 21 companies in 2025. Trend: 2023 $41,547 · 2024 $58,412 · 2025 $41,339
Speaker / faculty: $28,327Food & beverage: $5,795Consulting: $3,970Travel & lodging: $3,248
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 64 | $16,031 |
| Regeneron Healthcare Solutions, Inc. | 20 | $6,788 |
| Janssen Biotech, Inc. | 22 | $5,526 |
| Novartis Pharmaceuticals Corporation | 20 | $5,390 |
| GENZYME CORPORATION | 13 | $3,923 |
| Journey Medical Corporation | 3 | $746 |
| LEO Pharma Inc. | 22 | $702 |
| UCB, Inc. | 20 | $640 |
| Galderma Laboratories, L.P. | 20 | $416 |
| Lilly USA, LLC | 8 | $200 |
Products named: RINVOQ, DUPIXENT, TREMFYA, COSENTYX, SKYRIZI, Bimzelx, ADBRY, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
